Medium
by Andrii Buvailo
January 15, 2019
The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a surge of activity in this area over the last several years. In 2018, things are getting even “hotter” with the increase in the amount of partnerships, investments and other important events, summarized and grouped below into “mini-trends”.
1. Venture capital is pouring into AI-driven drug discovery startups
This year has been marked by an impressive number of fundraising deals among AI-driven drug discovery startups — a clear indication of the “AI for drug discovery” space gaining some serious attractiveness for venture capitalists...
